PPase Inhibitors
PPase inhibitors, or pyrophosphatase inhibitors, are a class of chemical compounds that target and inhibit the activity of pyrophosphatases (PPases). PPases are enzymes that catalyze the hydrolysis of inorganic pyrophosphate (PPi) into two orthophosphate (Pi) molecules, a reaction essential for various biochemical processes. This hydrolytic reaction releases energy that can drive many cellular activities, including nucleotide synthesis, protein folding, and membrane transport. Inorganic pyrophosphate serves as a byproduct in many biosynthetic pathways, and its accumulation can be detrimental to cellular function. By regulating the concentration of PPi, PPases play a crucial role in maintaining metabolic equilibrium. PPase inhibitors work by binding to the enzyme's active site or an allosteric site, effectively preventing the breakdown of pyrophosphate, which can lead to alterations in these energy-dependent processes.
Structurally, PPase inhibitors can exhibit a wide range of chemical diversity, with some mimicking the transition state of the PPi hydrolysis reaction to enhance their binding affinity to the enzyme. Metal ions, such as magnesium or manganese, which are often cofactors for PPase function, can also be targeted by specific inhibitors to disrupt the enzyme's activity. These inhibitors are frequently used in biochemical studies to understand the regulatory mechanisms governing energy metabolism, protein synthesis, and ion homeostasis in cells. Furthermore, they are valuable in elucidating the role of PPases in prokaryotic and eukaryotic organisms, as these enzymes are highly conserved across species. The inhibition of PPase activity can, therefore, provide critical insights into metabolic pathways that depend on efficient pyrophosphate turnover, revealing fundamental aspects of cellular bioenergetics and enzyme function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate may downregulate PPase expression by inhibiting dihydrofolate reductase, leading to a decrease in thymidylate synthesis and subsequent DNA replication and cell proliferation. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride could inhibit PPase expression by mimicking the phosphate group, potentially disrupting phosphate signaling and homeostasis, leading to a decrease in PPase gene transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may decrease PPase expression by inhibiting histone deacetylase, resulting in hyperacetylation of histones and alteration of gene expression patterns, including those governing PPase. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could downregulate PPase expression by causing DNA demethylation, which may lead to the repression of gene transcription through epigenetic remodeling. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may decrease PPase expression by activating sirtuin pathways, which can lead to the deacetylation of histones and suppression of specific gene expression, including PPase. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin could downregulate PPase expression by inhibiting the activation of transcription factors such as NF-κB, which may decrease the transcription of genes involved in the inflammatory response, including PPase. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid, all trans may reduce PPase expression by binding to retinoic acid receptors, which can alter the transcription of genes involved in cell differentiation and proliferation, potentially including those encoding PPase. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride could decrease PPase expression by inhibiting GSK-3, which may alter downstream signaling pathways such as Wnt, leading to changes in gene transcription patterns including PPase. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin may inhibit PPase expression by blocking the mevalonate pathway, leading to a reduction in cholesterol synthesis and potentially other isoprenoids that play a role in cell signaling and PPase gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin might decrease PPase expression by specifically inhibiting mTOR, a key regulator of cell growth and protein synthesis, thereby reducing the transcription and translation of many genes, including PPase. | ||||||